Notice of Intent to Issue a Sole Source Award Tender - 141572889

Procurement Summary

Country: USA

Summary: Notice of Intent to Issue a Sole Source Award to Generate and Optimize Highaffinity Nucleic Acid Aptamers Capable of Semiquantitative Detection of Tfvdp Andor Tfv for Use in both Platebased Assays and...

Deadline: 02 Jun 2026

Posting Date: 19 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 141572889

Document Ref. No.: 75D30126R73457

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Notice of Intent to Issue a Sole Source Award to Generate and Optimize Highaffinity Nucleic Acid Aptamers Capable of Semiquantitative Detection of Tfvdp Andor Tfv for Use in both Platebased Assays and Poc Platforms
The Centers for Disease Control and Prevention Division of HIV Prevention (DHP)/Laboratory Branch intends to award a sole source Firm-fixed-price purchase order to the University of North Carolina at Chapel Hill, Department of Chemistry to generate and optimize high-affinity nucleic acid aptamers capable of semi-quantitative detection of TFV-DP and/or TFV for use in both plate-based assays and POC platforms. This contract action is for commercial services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102-1. NAICS 541715 - Medical Research and Development Laboratories or Services (except Biotechnology and Nanotechnology Research and Development). UNC was identified as uniquely qualified due to its role as a co-inventor of the FTC aptamer previously developed for ARV detection research, and established methodologies compatible with CDC-s current assay development efforts. UNC is the only source reasonably available capable of performing the required work within the required timeframe and technical specifications. Changing to another vendor-s aptamer would severely impact the CDC-s progress in this area, requiring a start over of the entire process of optimization and would not be compatible with the already developed, existing aptamer detecting emtricitabine. This notice of intent is not a request for competitive quotations; however, all Quotations/ responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to complete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determini...
Notice ID: 75d30126r73457

Department/Ind. Agency: health and human services, department of

Sub-tier: centers for disease control and prevention

Office: cdc office of acquisition services

Product Service Code: aj12 - general science and technology r&d services; general science and technology; applied research

NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Inactive Dates: jun 17, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice